ArticleHealthcare (Basel, Switzerland)2020
Developing Sustainable Classification of Diseases via Deep Learning and Semi-Supervised Learning.
Article in Healthcare (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transformer Architecture and Attention Mechanisms in Genome Data Analysis: A Comprehensive Review.Biology · 2023Review
- Machine Learning Methods for Small Data Challenges in Molecular Science.Chemical reviews · 2023Review
- A Lightweight Convolutional Neural Network Architecture Applied for Bone Metastasis Classification in Nuclear Medicine: A Case Study on Prostate Cancer Patients.Healthcare (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Disease classification based on machine learning has become a crucial research topic in the fields of genetics and molecular biology. Generally, disease classification involves a supervised learning style; i.e., it requires a large number of labelled samples to achieve good classification performance. However, in the majority of the cases, labelled samples are hard to obtain, so the amount of training data are limited. However, many unclassified (unlabelled) sequences have been deposited in public databases, which may help the training procedure. This method is called semi-supervised learning and is very useful in many applications. Self-training can be implemented using high- to low-confidence samples to prevent noisy samples from affecting the robustness of semi-supervised learning in the training process. The deep forest method with the hyperparameter settings used in this paper can achieve excellent performance. Therefore, in this work, we propose a novel combined deep learning model and semi-supervised learning with self-training approach to improve the performance in disease classification, which utilizes unlabelled samples to update a mechanism designed to increase the number of high-confidence pseudo-labelled samples. The experimental results show that our proposed model can achieve good performance in disease classification and disease-causing gene identification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.